SCHEMBL3602663

SCHEMBL3602663

O=C(O)c1cnn(Cc2cccc3ccccc23)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.47
TDP1 Q9NUW8 2/20 0.46
HSP90AB1 P08238 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
LMNA P02545 1/20 0.46
PKM P14618 1/20 0.46
EGLN1 Q9GZT9 1/20 0.45
GAA P10253 2/20 0.45
KMT2A Q03164 1/20 0.45
HPGDS O60760 1/20 0.44
ALKBH2 Q6NS38 1/20 0.44
POLB P06746 1/20 0.44
KDM4A O75164 1/20 0.44
KDM4C Q9H3R0 1/20 0.44
CTNNB1 P35222 1/20 0.43
KLKB1 P03952 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CMA1 P23946 1/20 0.42
MCL1 Q07820 1/20 0.42
BAD Q92934 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3606815 0.82 MAPT (0.46) L3MBTL1TDP1HSP90AB1SMN1; SMN2LMNA
SCHEMBL15155184 0.80 L3MBTL1 (0.64) L3MBTL1TDP1SMN1; SMN2LMNAPKM
SCHEMBL15155096 0.80 LMNA (0.57) L3MBTL1TDP1SMN1; SMN2LMNAEGLN1
SCHEMBL15155139 0.80 ALDH1A1 (0.55) L3MBTL1SMN1; SMN2LMNAPKMKMT2A
SCHEMBL3606843 0.80 MAPT (0.63) L3MBTL1HSP90AB1LMNAPKMKMT2A
SCHEMBL553830 0.77 L3MBTL1 (0.62) L3MBTL1TDP1HPGDSALKBH2POLB
SCHEMBL15155001 0.77 CREBBP (0.57) L3MBTL1SMN1; SMN2EGLN1HPGDSALKBH2
SCHEMBL28760613 0.77 EPHX2 (0.51) L3MBTL1TDP1PKMGAAKMT2A
SCHEMBL18586270 0.76 HSP90AB1 (0.47) L3MBTL1HSP90AB1SMN1; SMN2LMNAPKM
SCHEMBL14692522 0.76 L3MBTL1 (0.48) L3MBTL1TDP1LMNAPKMEGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100041696-A1 Compounds SMITHKLINE BEECHAM CORPORATION 2010-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041696-A1 Compounds CYP11B2, SCD, CYP3A5 L3MBTL1 4424/4885TDP1 1525/4885HSP90AB1 3802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.